Avoiding Night‐time Fluid Retention in CAPD Patients

with CAPD 4-6 hrs To the Editor: For many continuous ambulatory peritoneal dialysis patients, the long night-time exchange presents many disadvantages: (a) the retention of fluid in patients with decreased ultrafiltration capacity necessitates a greater use of hypertonic glucose solution during the day, which in turn leads to an increased glucose intake, hyperinsulinemia, obesity, and malnutrition (1-7). The use of hypertonic glucose solution also causes a greater loss of protein in the dialysate (8, 9). (6) Patients with a high peritoneal transport rate may also end up with decreased clearance of small and middle molecules during the long dwell exchange as a result of the reduction in drain volume (10, 1 1). These patients frequently have increased lymphatic absorption, further contributing to a decrease in solute clearance ( 12, 1 3) . In patients who have loss of ultrafiltration capacity and are high transporters, reducing the 8to 9-hour exchange during the night to a 4-hour exchange will probably not interfere with the quality of dialysis, as there will be a better clearance of small and middle molecules. By programming their alarm clock to ring at approximately 3:OO or 4:OO a.m., they could wake up, open the clamp, and allow their abdomen to empty, improving night-time clearances and fluid balance, Interference with sleep is a major disadvantage to such an approach. We would like to suggest a simple device to shorten the long night-time dwell without awakening the patient. The use of a dialysis bag with a long tube connected to the patient and a timer-clock clamp could allow the peritoneal dialysis fluid to automatically empty (Fig. 1). This approach would change the 8to 9-hour night-time exchange to a 4-hour dwell with all its advantages and without significant inconvenience (Fig. 2). mn

[1]  W. Kast,et al.  Pretransplantation blood transfusion revisited. , 1991, The New England journal of medicine.

[2]  W. Keane,et al.  Adjunctive therapy with intravenous human immunoglobulin G improves survival of patients with acute renal failure. , 1991, Journal of the American Society of Nephrology : JASN.

[3]  A. Bellucci,et al.  Mortality in dialysis patients: analysis of the causes of death. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  J. Rubin,et al.  An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  H. Bhagavan,et al.  Ascorbic acid supplements in patients receiving chronic peritoneal dialysis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  A. Kostakis,et al.  Tumor markers in patients undergoing hemodialysis or kidney transplantation. , 1991, Nephron.

[7]  A. Davenport,et al.  Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients. , 1991, Nephron.

[8]  J. Stephenson,et al.  Epidemiology of CAPD-associated peritonitis caused by coagulase-negative staphylococci: comparison of strains isolated from hands, abdominal Tenckhoff catheter exit site and peritoneal fluid. , 1991, Nephrology, Dialysis and Transplantation.

[9]  A. Donker,et al.  Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo. , 1991, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[10]  R. Sherman Can CAPD Run on Empty? Arguments for Elimination of the Overnight Dwell , 1990 .

[11]  Y. Bar-Khayim,et al.  Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels. , 1990, Kidney international.

[12]  Z. Twardowski Nightly peritoneal dialysis. Why, who, how, and when? , 1990, ASAIO transactions.

[13]  C. Rudge,et al.  Treatment of resistant CAPD peritonitis by temporary discontinuation of peritoneal dialysis. , 1989, Clinical nephrology.

[14]  W. Keane,et al.  Host Defense Mechanisms in Chronic Ambulatory Peritoneal Dialysis—Associated Peritonitis , 1989 .

[15]  K. Nolph,et al.  Ultrafiltration failure in continuous ambulatory peritoneal dialysis due to excessive peritoneal cavity lymphatic absorption. , 1987, American Journal of Kidney Diseases.

[16]  R. Wilkinson,et al.  OUTCOME IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS AND HAEMODIALYSIS: 4-YEAR ANALYSIS OF A PROSPECTIVE MULTICENTRE STUDY , 1987, The Lancet.

[17]  K. Nolph,et al.  Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis. , 1987, The Journal of clinical investigation.

[18]  J. Díaz-Buxó,et al.  Continuous cyclic peritoneal dialysis: a preliminary report. , 1981, Artificial organs.

[19]  J. Kopple,et al.  Protein losses during peritoneal dialysis. , 1981, Kidney international.

[20]  J. Kopple,et al.  Glucose absorption during continuous ambulatory peritoneal dialysis. , 1981, Kidney international.

[21]  R. Torella,et al.  Glucose utilization from dialysate in patients on continuous ambulatory peritoneal dialysis (CAPD). , 1979, The International journal of artificial organs.

[22]  C. T. Flynn,et al.  Intraperitoneal insulin with CAPD - an artificial pancreas. , 1979, Transactions - American Society for Artificial Internal Organs.

[23]  K. Nolph,et al.  Differences in solute sieving with osmotic vs hydrostatic ultrafiltration. , 1976, Transactions - American Society for Artificial Internal Organs.

[24]  A. Gray Letter: Nothing much for the nurses. , 1974, Lancet.

[25]  E. Hultman,et al.  Glucose absorption from the dialysis fluid during peritoneal dialysis. , 1971, Scandinavian journal of urology and nephrology.

[26]  F. Epstein,et al.  Hyperglycemia and hyperosmolality complicating peritoneal dialysis. , 1967, Annals of internal medicine.